Moreover, in human colon cancer cell lines, lipopolysaccharide (LPS) treatment increases the expression levels of NOX1 and NOX2 expression, and NF-κB inhibitor attenuates the increase in NOX1 and NOX2 expression [26]. The gene discussed is CYBB; the disease is malignant colon neoplasm.